Cationic peptides: a new source of antibiotics.

PubWeight™: 5.10‹?› | Rank: Top 1%

🔗 View Article (PMID 9487736)

Published in Trends Biotechnol on February 01, 1998

Authors

R E Hancock1, R Lehrer

Author Affiliations

1: Department of Microbiology and Immunology, University of British Columbia, Vancouver, Canada.

Articles citing this

(truncated to the top 100)

Peptide antimicrobial agents. Clin Microbiol Rev (2006) 6.04

Peptide antibiotics. Antimicrob Agents Chemother (1999) 5.76

Designing antimicrobial peptides: form follows function. Nat Rev Drug Discov (2011) 4.16

The role of antimicrobial peptides in animal defenses. Proc Natl Acad Sci U S A (2000) 3.52

Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3. Proc Natl Acad Sci U S A (2003) 2.32

Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index. J Biol Chem (2005) 2.28

Bactericidal activity of mammalian cathelicidin-derived peptides. Infect Immun (2000) 2.24

Production of beta-defensin antimicrobial peptides by the oral mucosa and salivary glands. Infect Immun (1999) 2.19

Antibacterial activity and specificity of the six human {alpha}-defensins. Antimicrob Agents Chemother (2005) 2.11

Structure--activity relationships of polymyxin antibiotics. J Med Chem (2010) 2.03

A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs. Curr Eye Res (2005) 1.97

De novo design of biomimetic antimicrobial polymers. Proc Natl Acad Sci U S A (2002) 1.95

ANTIMIC: a database of antimicrobial sequences. Nucleic Acids Res (2004) 1.88

Membrane-dependent oligomeric structure and pore formation of a beta-hairpin antimicrobial peptide in lipid bilayers from solid-state NMR. Proc Natl Acad Sci U S A (2006) 1.87

Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides. Antimicrob Agents Chemother (2006) 1.87

Human beta-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection. J Virol (2005) 1.75

De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity. Antimicrob Agents Chemother (2005) 1.70

Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli. Antimicrob Agents Chemother (2002) 1.69

De novo design and in vivo activity of conformationally restrained antimicrobial arylamide foldamers. Proc Natl Acad Sci U S A (2009) 1.58

Human cathelicidin (LL-37), a multifunctional peptide, is expressed by ocular surface epithelia and has potent antibacterial and antiviral activity. Curr Eye Res (2005) 1.58

Synergistic interactions between mammalian antimicrobial defense peptides. Antimicrob Agents Chemother (2001) 1.56

Solid-state NMR investigation of the depth of insertion of protegrin-1 in lipid bilayers using paramagnetic Mn2+. Biophys J (2003) 1.55

Antimicrobial polymers prepared by ROMP with unprecedented selectivity: a molecular construction kit approach. J Am Chem Soc (2008) 1.54

Effects of net charge and the number of positively charged residues on the biological activity of amphipathic alpha-helical cationic antimicrobial peptides. Biopolymers (2008) 1.51

Human beta-defensin 3 inhibits cell wall biosynthesis in Staphylococci. Infect Immun (2010) 1.48

Biomolecular engineering by combinatorial design and high-throughput screening: small, soluble peptides that permeabilize membranes. J Am Chem Soc (2008) 1.46

Biological properties of structurally related alpha-helical cationic antimicrobial peptides. Infect Immun (1999) 1.40

Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5. Antimicrob Agents Chemother (2001) 1.36

Antibacterial properties of dermaseptin S4 derivatives with in vivo activity. Antimicrob Agents Chemother (2002) 1.36

The lipid A 1-phosphatase of Helicobacter pylori is required for resistance to the antimicrobial peptide polymyxin. J Bacteriol (2006) 1.33

Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide. Antimicrob Agents Chemother (1999) 1.32

Structure, membrane orientation, mechanism, and function of pexiganan--a highly potent antimicrobial peptide designed from magainin. Biochim Biophys Acta (2008) 1.31

Models of toxic beta-sheet channels of protegrin-1 suggest a common subunit organization motif shared with toxic alzheimer beta-amyloid ion channels. Biophys J (2008) 1.30

Antimicrobial peptides in 2014. Pharmaceuticals (Basel) (2015) 1.30

De novo designed synthetic mimics of antimicrobial peptides. Curr Opin Biotechnol (2008) 1.30

Effects of histatin 5 and derived peptides on Candida albicans. Biochem J (2001) 1.26

Functional interaction of human neutrophil peptide-1 with the cell wall precursor lipid II. FEBS Lett (2010) 1.26

Antibacterials from the sea. Chemistry (2010) 1.25

DAMPD: a manually curated antimicrobial peptide database. Nucleic Acids Res (2011) 1.24

Comparison of biophysical and biologic properties of alpha-helical enantiomeric antimicrobial peptides. Chem Biol Drug Des (2006) 1.20

Mechanism of a prototypical synthetic membrane-active antimicrobial: Efficient hole-punching via interaction with negative intrinsic curvature lipids. Proc Natl Acad Sci U S A (2008) 1.20

Naturally processed dermcidin-derived peptides do not permeabilize bacterial membranes and kill microorganisms irrespective of their charge. Antimicrob Agents Chemother (2006) 1.18

Adding selectivity to antimicrobial peptides: rational design of a multidomain peptide against Pseudomonas spp. Antimicrob Agents Chemother (2006) 1.17

Platelet factor 4 activity against P. falciparum and its translation to nonpeptidic mimics as antimalarials. Cell Host Microbe (2012) 1.16

Cationic antimicrobial polymers and their assemblies. Int J Mol Sci (2013) 1.16

Characterization of unique amphipathic antimicrobial peptides from venom of the scorpion Pandinus imperator. Biochem J (2001) 1.14

Phosphoinositide-mediated oligomerization of a defensin induces cell lysis. Elife (2014) 1.11

Cationic hydrophobic peptides with antimicrobial activity. Antimicrob Agents Chemother (2002) 1.10

Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis. Antimicrob Agents Chemother (2001) 1.10

Angiotensin I-converting-enzyme-inhibitory and antibacterial peptides from Lactobacillus helveticus PR4 proteinase-hydrolyzed caseins of milk from six species. Appl Environ Microbiol (2003) 1.10

Protease inhibitors from plants with antimicrobial activity. Int J Mol Sci (2009) 1.08

Identification of genes associated with survival of Salmonella enterica serovar Enteritidis in chicken egg albumen. Appl Environ Microbiol (2006) 1.08

Rational design of α-helical antimicrobial peptides to target Gram-negative pathogens, Acinetobacter baumannii and Pseudomonas aeruginosa: utilization of charge, 'specificity determinants,' total hydrophobicity, hydrophobe type and location as design parameters to improve the therapeutic ratio. Chem Biol Drug Des (2011) 1.07

Database screening and in vivo efficacy of antimicrobial peptides against methicillin-resistant Staphylococcus aureus USA300. Int J Antimicrob Agents (2012) 1.06

Conjugation of fatty acids with different lengths modulates the antibacterial and antifungal activity of a cationic biologically inactive peptide. Biochem J (2005) 1.06

High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments. Biochim Biophys Acta (2014) 1.05

NMR structure of pardaxin, a pore-forming antimicrobial peptide, in lipopolysaccharide micelles: mechanism of outer membrane permeabilization. J Biol Chem (2009) 1.05

MSI-99, a magainin analogue, imparts enhanced disease resistance in transgenic tobacco and banana. Planta (2002) 1.04

Inhibition of plant-pathogenic bacteria by short synthetic cecropin A-melittin hybrid peptides. Appl Environ Microbiol (2006) 1.04

Enhancement of antimicrobial activity against pseudomonas aeruginosa by coadministration of G10KHc and tobramycin. Antimicrob Agents Chemother (2006) 1.03

Histatin 5 uptake by Candida albicans utilizes polyamine transporters Dur3 and Dur31 proteins. J Biol Chem (2011) 1.02

Human salivary mucin MUC7 12-mer-L and 12-mer-D peptides: antifungal activity in saliva, enhancement of activity with protease inhibitor cocktail or EDTA, and cytotoxicity to human cells. Antimicrob Agents Chemother (2005) 1.02

Arginine dynamics in a membrane-bound cationic beta-hairpin peptide from solid-state NMR. Chembiochem (2008) 1.01

Defensins and other antimicrobial peptides at the ocular surface. Ocul Surf (2004) 1.00

Surface-active fungicidal D-peptide inhibitors of the plasma membrane proton pump that block azole resistance. Antimicrob Agents Chemother (2005) 1.00

Probing the penetration of antimicrobial polymyxin lipopeptides into gram-negative bacteria. Bioconjug Chem (2014) 0.99

HIV is inactivated after transepithelial migration via adult oral epithelial cells but not fetal epithelial cells. Virology (2010) 0.99

Peptide design for antimicrobial and immunomodulatory applications. Biopolymers (2013) 0.99

Solution structure of a novel tryptophan-rich peptide with bidirectional antimicrobial activity. J Bacteriol (2006) 0.98

Genetic analysis and complete primary structure of microcin L. Antimicrob Agents Chemother (2004) 0.98

Computational studies of protegrin antimicrobial peptides: a review. Peptides (2010) 0.97

The synthetic N-terminal peptide of human lactoferrin, hLF(1-11), is highly effective against experimental infection caused by multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother (2004) 0.97

A folding-dependent mechanism of antimicrobial peptide resistance to degradation unveiled by solution structure of distinctin. Proc Natl Acad Sci U S A (2005) 0.96

Novel synthetic antimicrobial peptides against Streptococcus mutans. Antimicrob Agents Chemother (2007) 0.96

Dimerization of plant defensin NaD1 enhances its antifungal activity. J Biol Chem (2012) 0.96

Structure and association of human lactoferrin peptides with Escherichia coli lipopolysaccharide. Antimicrob Agents Chemother (2004) 0.95

Activities of antimicrobial peptides and synergy with enrofloxacin against Mycoplasma pulmonis. Antimicrob Agents Chemother (2006) 0.95

Synergy of histone-derived peptides of coho salmon with lysozyme and flounder pleurocidin. Antimicrob Agents Chemother (2001) 0.95

Antibacterial properties of dermaseptin S4 derivatives under extreme incubation conditions. Antimicrob Agents Chemother (2006) 0.95

Structure and function of papiliocin with antimicrobial and anti-inflammatory activities isolated from the swallowtail butterfly, Papilio xuthus. J Biol Chem (2011) 0.94

Mucroporin, the first cationic host defense peptide from the venom of Lychas mucronatus. Antimicrob Agents Chemother (2008) 0.94

Evolution of caprine and ovine beta-defensin genes. Immunogenetics (2005) 0.94

Proteolytic degradation of human antimicrobial peptide LL-37 by Bacillus anthracis may contribute to virulence. Antimicrob Agents Chemother (2006) 0.94

Involvement of the pepper antimicrobial protein CaAMP1 gene in broad spectrum disease resistance. Plant Physiol (2008) 0.94

Conformational study of the protegrin-1 (PG-1) dimer interaction with lipid bilayers and its effect. BMC Struct Biol (2007) 0.93

Mechanism of action and initial evaluation of a membrane active all-D-enantiomer antimicrobial peptidomimetic. Proc Natl Acad Sci U S A (2013) 0.93

Imcroporin, a new cationic antimicrobial peptide from the venom of the scorpion Isometrus maculates. Antimicrob Agents Chemother (2009) 0.93

Antimicrobial peptides protect coho salmon from Vibrio anguillarum infections. Appl Environ Microbiol (2000) 0.92

Dermcidin-derived peptides show a different mode of action than the cathelicidin LL-37 against Staphylococcus aureus. Antimicrob Agents Chemother (2009) 0.92

Identification and mechanism of action of the plant defensin NaD1 as a new member of the antifungal drug arsenal against Candida albicans. Antimicrob Agents Chemother (2013) 0.92

Oral antimicrobial peptides: Types and role in the oral cavity. Saudi Pharm J (2015) 0.92

Expression of the antimicrobial peptides in plants to control phytopathogenic bacteria and fungi. Plant Cell Rep (2006) 0.92

Synthetic histidine-rich peptides inhibit Candida species and other fungi in vitro: role of endocytosis and treatment implications. Antimicrob Agents Chemother (2006) 0.91

De-novo design of antimicrobial peptides for plant protection. PLoS One (2013) 0.91

Comparison of interactions between beta-hairpin decapeptides and SDS/DPC micelles from experimental and simulation data. BMC Biochem (2007) 0.91

Factors affecting antimicrobial activity of MUC7 12-mer, a human salivary mucin-derived peptide. Ann Clin Microbiol Antimicrob (2007) 0.91

Histidine phosphotransfer proteins in fungal two-component signal transduction pathways. Eukaryot Cell (2013) 0.91

Synergistic effects and antibiofilm properties of chimeric peptides against multidrug-resistant Acinetobacter baumannii strains. Antimicrob Agents Chemother (2013) 0.90

A chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci. Antimicrob Agents Chemother (2004) 0.90

Curvularia haloperoxidase: antimicrobial activity and potential application as a surface disinfectant. Appl Environ Microbiol (2003) 0.90

Articles by these authors

Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria. Clin Infect Dis (1998) 3.46

Monocyte-chemotactic activity of defensins from human neutrophils. J Clin Invest (1989) 2.50

Patterns of feeding behavior in the pigeon. J Comp Physiol Psychol (1971) 1.13

Possible involvement of (2'5')oligoadenylate synthetase activity in pre-mRNA splicing. Proc Natl Acad Sci U S A (1991) 0.87

Antibacterial in vitro activity of fourth generation cephalosporins. J Chemother (1996) 0.83

A possible cardiovascular effect of lithium. Am J Psychiatry (1979) 0.82

The role of fundamental research and biotechnology in finding solutions to the global problem of antibiotic resistance. Clin Infect Dis (1997) 0.81

The human (2'-5') oligo A synthetase gene, structure of its two enzyme products and quick cell blot for clinical monitoring of its activation by interferons. Prog Clin Biol Res (1985) 0.80

Uterine blood flow in relation to endogenous hormones during estrous cycle and early pregnancy. Am J Physiol (1983) 0.78

Shigellae control the Gates of LL. Nat Med (2001) 0.75

Expression, purification, crystallization and preliminary X-ray analysis of the cathelicidin motif of the protegrin-3 precursor. Acta Crystallogr D Biol Crystallogr (2001) 0.75

Inferences of mental illness from noninvolvement. J Pers (1983) 0.75

Sézary syndrome. Tartrate-resistant acid phosphatase in the neoplastic cells. Am J Clin Pathol (1979) 0.75

Specific regulation of the 100 kDa 2-5 A synthetase by protein kinase C. Eur Cytokine Netw (1992) 0.75

The effect of enhanced milk yield of dairy cows by frequent milking or suckling on intake and digestibility of the diet. J Dairy Sci (1998) 0.75

The effect of parabiosis on audiogenic convulsions in seizure-susceptible mice. Exp Neurol (1970) 0.75